Shanghai Junshi Biosciences Co., Ltd. Class H(HK:1877)
HK$15.67-0.27 (-1.69%)
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H financials statements
HK$15.67
At close:-0.27 (-1.69%)
Want to see HK:1877 full AI Analyst Report?
Shanghai Junshi Biosciences Co., Ltd. Class H (1877) Financial Statements
4 Followers
Shanghai Junshi Biosciences Co., Ltd. Class H Financial Overview
Shanghai Junshi Biosciences Co., Ltd. Class H's market cap is currently ¥32.01B. The company's EPS TTM is ¥-0.39; its P/E ratio is -73.23; Shanghai Junshi Biosciences Co., Ltd. Class H is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is ¥-0.04. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 2.43B | ¥ 1.95B | ¥ 1.50B | ¥ 1.45B | ¥ 4.02B |
| Gross Profit | ¥ 1.97B | ¥ 1.54B | ¥ 835.26M | ¥ 927.21M | ¥ 2.77B |
| Operating Income | ¥ -909.40M | ¥ -1.34B | ¥ -2.45B | ¥ -2.75B | ¥ -592.71M |
| EBITDA | ¥ -599.38M | ¥ -882.37M | ¥ -2.16B | ¥ -2.47B | ¥ -423.50M |
| Net Income | ¥ -851.76M | ¥ -1.28B | ¥ -2.28B | ¥ -2.39B | ¥ -718.56M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 3.22B | ¥ 2.93B | ¥ 3.78B | ¥ 6.00B | ¥ 3.50B |
| Total Assets | ¥ 12.39B | ¥ 10.80B | ¥ 11.36B | ¥ 12.58B | ¥ 11.05B |
| Total Debt | ¥ 4.14B | ¥ 2.93B | ¥ 1.79B | ¥ 1.32B | ¥ 628.20M |
| Net Debt | ¥ 1.53B | ¥ 428.69M | ¥ -1.99B | ¥ -4.68B | ¥ -2.88B |
| Total Liabilities | ¥ 6.16B | ¥ 4.85B | ¥ 4.02B | ¥ 2.78B | ¥ 2.72B |
| Stockholders' Equity | ¥ 6.03B | ¥ 5.86B | ¥ 7.17B | ¥ 9.50B | ¥ 7.96B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -1.21B | ¥ -2.12B | ¥ -2.85B | ¥ -2.17B | ¥ -1.53B |
| Operating Cash Flow | ¥ -465.77M | ¥ -1.43B | ¥ -2.01B | ¥ -1.78B | ¥ -641.90M |
| Investing Cash Flow | ¥ -1.58B | ¥ -892.78M | ¥ -892.42M | ¥ -467.62M | ¥ -1.88B |
| Financing Cash Flow | ¥ 2.17B | ¥ 1.02B | ¥ 681.04M | ¥ 4.64B | ¥ 2.67B |
Currency in CNY
